Memo Therapeutics
Memo Therapeutics AG ("MTx"), an Ipsen company, is a late-stage biotechnology company headquartered at Wagistrasse 27 in Schlieren / Zurich, Switzerland, with a US office as Memo Therapeutics US, Inc. in Wilson, North Carolina. It develops best-in-class therapeutic antibodies to transform the lives of patients with viral infections and cancer, built on DROPZYLLA, a microfluidic single-cell platform that makes a recombinant in vitro copy of an individual donor's B-cell antibody repertoire, banks it as a library, and screens it functionally at high throughput. Its lead program, potravitug, is a first-in-class monoclonal antibody against BK polyomavirus (BKPyV) reactivation in kidney transplant recipients; the Phase II SAFE KIDNEY II trial reported biopsy-proven resolution of BKPyV-associated nephropathy with sustained viral-load reduction to week 38, and the asset holds EU orphan designation. In February 2026 the company entered a collaboration and option agreement with CSL for its recombinant polyclonal IgG technology carrying milestones of up to CHF 265 million, and it has run an oncology antibody-discovery collaboration with Ono Pharmaceutical since 2022 alongside nephrology collaborations with the University Hospital of Zurich and the University Hospital of Bern. Ipsen completed its acquisition of Memo Therapeutics AG on 22 July 2026, adding potravitug to Ipsen's rare-disease pipeline. Memo Therapeutics runs no developer program and publishes no product API, developer portal, SDK or API documentation. The only machine-readable surface reachable without credentials is the WordPress REST content API behind memo-therapeutics.com, catalogued here, together with an llms.txt the site's SEO plugin publishes.
Limited machine-readable signal and partial portal coverage — documentation a human can read, but little a machine or agent can consume without scraping.
API Evangelist profiles Memo Therapeutics the way a machine reads it — 13 machine-readable artifacts across 9 APIs, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Memo Therapeutics scores 32.3/100 (thin), with a separate agent-readiness read of 22/100 (agent aware). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance. Every facet and dimension name is a link: it opens that measurement's page on APIs.io, where the rating runs across the whole catalog — the exact checks that feed it, how every profiled provider distributes on it, and who is at the top of it.
Kin Score
How this is scored →scored 2026-09-01 · rubric v0.18.0
Put this on your own site. The badge is drawn live from Memo Therapeutics's current Kin Score — paste it once and it updates itself every time the score is recomputed. It follows your visitor's light or dark setting, and it links back here so anyone who sees it can read the full breakdown.
<!-- Kin Score · API Evangelist -->
<a href="https://providers.apievangelist.com/providers/memo-therapeutics/"
title="Memo Therapeutics on API Evangelist — API profile and Kin Score">
<img src="https://apis.io/badge/memo-therapeutics.svg"
alt="Memo Therapeutics Kin Score — API readiness rating by API Evangelist" width="150" height="150" loading="lazy">
</a>[](https://providers.apievangelist.com/providers/memo-therapeutics/)<!-- Kin Score · API Evangelist -->
<a href="https://providers.apievangelist.com/providers/memo-therapeutics/"
title="Memo Therapeutics on API Evangelist — API profile and Kin Score">
<img src="https://apis.io/badge/memo-therapeutics/card.svg"
alt="Memo Therapeutics Kin Score — API readiness rating by API Evangelist" width="340" height="120" loading="lazy">
</a>More shapes, themes and sizes → · Score as JSON · How badges work
How we profile Memo Therapeutics
Each block below is one kind of artifact we hold for Memo Therapeutics. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
APIs 9
Each API is captured as its own OpenAPI definition — every operation, parameter, and response. This is the single most useful machine-readable description of what an API does, and it's what lets us score, lint, mock, and generate against it without asking the provider for anything.
Individual APIs this provider publishes, each with its own machine-readable definition.
Memo Therapeutics Posts API
News archive — press releases, Q&A interviews, event listings and scientific presentations (36 published on 2026-08-25).
Memo Therapeutics Pages API
Corporate pages — About us, BKV, Contact us, Latest News, Further Information, Expanded Access Policy, and the privacy, cookie and terms documents (10 published on 2026-08-25).
Memo Therapeutics Media API
Media library — corporate imagery, partner and investor logos and leadership portraits (163 attachments on 2026-08-25).
Memo Therapeutics Taxonomy API
Categories and tags. Eight categories are registered and populated; the post_tag taxonomy is registered but empty.
Memo Therapeutics Comments API
Comment collection. Registered and anonymously reachable, but empty — no post on this deployment carries comments.
Memo Therapeutics Search API
Cross-content search across published objects (154 searchable objects on 2026-08-25).
Memo Therapeutics Discovery API
Route, namespace, type, taxonomy and status discovery documents — the machine-readable index this profile was derived from.
Memo Therapeutics oEmbed API
oEmbed 1.0 provider endpoint for memo-therapeutics.com URLs.
Memo Therapeutics Navigation API
Block-theme navigation menus exposed as a post type (1 published on 2026-08-25).
Scroll within the panel for all 9 ·
Pricing Plans 1
Pricing is part of the interface. Machine-readable plans tell you what a tier costs and includes before you commit — one of the things the Kin Score reads for access clarity — renamed from commercial clarity in rubric 0.12, because a free statutory interface has access terms and no commercial ones.
Published pricing tiers and plan structures.
Rate Limits 1
Rate limits are the difference between a demo that works and a production integration that doesn't fall over. Publishing them is an operational-transparency signal — and a hard requirement for any agent that plans its own throughput.
Documented rate limits and quota policies.
Memo Therapeutics Rate Limits
RATE LIMITSSecurity Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Every other property we hold for Memo Therapeutics — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Agent Surfaces 2
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 5
Pagination, idempotency, versioning, errors, and events
Access & Security 2
Authentication, authorization, and security posture
Operate 2
Status, limits, changes, and where to get help
Commercial 3
Pricing, plans, and the legal terms of use
Company 6
The organization behind the API
Other 7
Properties that don't map to a standard resource type
Scroll within the panel for all 7 ·
← All providers · Data indexed from github.com/api-evangelist/memo-therapeutics · machine-readable index on apis.io
This is an independent, third-party profile of Memo Therapeutics, published by API Evangelist. We do not operate, host, resell, or support these APIs, and we are not affiliated with or endorsed by the company unless stated above. Everything here is built from publicly available information — the company's own site, developer portal, documentation, public repositories, and the specifications it publishes for public use. Nothing is obtained by breaching a system, defeating an access control, or using credentials.
The Kin Score and Agent Readiness rating are independently calculated assessments of a company's public API artifacts, scored against a published rubric. They are not certifications, endorsements, security assessments, or audits.
Corrections, re-scores, and removal are free — no partnership or purchase required, and you do not need to justify the request. A removed company is recorded as unrated, never scored zero for having asked. Acknowledgement within one business day; removal within two.
info@apievangelist.com
·
Read the full data-sourcing policy →
On a security or compliance team? Put security in the subject line and
you will get a person, not a form — we will tell you exactly which public URLs this profile was built from.